- Contact Us
- Log In | Register
CBI’s 3rd annual Abuse Deterrent Formulations Summit is dedicated to providing forward-thinking strategies for demonstrating the safety and effectiveness of abuse deterrent formulations and to developing policies that promote access to proactive care for addictive diseases in a pain management setting. Join us to hear important input from chronic pain patient organizations, pain and addiction clinical experts, government officials, pharmaceutical manufacturers and payers on how abuse deterrent formulations of opioids (ADF) play a transformative role as part of integrative pain management. As regulatory requirements and patient expectations continue to evolve, how will you contribute to the conversations on the treatment of chronic pain?